Immune-based therapy for spinal cord repair: autologous macrophages and beyond

M Schwartz, E Yoles - Journal of neurotrauma, 2006 - liebertpub.com
Spinal cord injury is a devastating condition of the central nervous system (CNS), often resulting
in severe loss of tissue, functional impairment, and only limited repair. Studies over the …

Potential neuroprotective therapy for glaucomatous optic neuropathy

E Yoles, M Schwartz - Survey of ophthalmology, 1998 - Elsevier
Accumulating evidence points to the existence of a mechanism that may explain why
glaucomatous neuropathy continues to progress even after its primary cause, eg, high intraocular …

Potential treatment modalities for glaucomatous neuropathy: neuroprotection and neuroregeneration

M Schwartz, M Belkin, E Yoles, A Solomon - Journal of glaucoma, 1996 - journals.lww.com
Purpose: This article presents the rationale and an experimental strategy for the development
of new treatment modalities for glaucomatous neuropathy. Accumulating evidence …

Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy

G Moalem, R Leibowitz–Amit, E Yoles, F Mor… - Nature medicine, 1999 - nature.com
Autoimmunity to antigens of the central nervous system is usually considered detrimental. T
cells specific to a central nervous system self antigen, such as myelin basic protein, can …

Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion

E Hauben, O Butovsky, U Nevo, E Yoles… - Journal of …, 2000 - Soc Neuroscience
Partial injury to the spinal cord can propagate itself, sometimes leading to paralysis
attributable to degeneration of initially undamaged neurons. We demonstrated recently that …

Protective autoimmunity is a physiological response to CNS trauma

E Yoles, E Hauben, O Palgi, E Agranov… - Journal of …, 2001 - Soc Neuroscience
Primary damage caused by injury to the CNS is often followed by delayed degeneration of
initially spared neurons. Studies in our laboratory have shown that active or passive …

T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies

J Kipnis, E Yoles, Z Porat, A Cohen… - Proceedings of the …, 2000 - National Acad Sciences
We recently reported that the posttraumatic spread of degeneration in the damaged optic
nerve can be attenuated by the adoptive transfer of autoimmune T cells specific to myelin basic …

Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration.

E Yoles, LA Wheeler… - … ophthalmology & visual …, 1999 - iovs.arvojournals.org
PURPOSE: The neurodegenerative progression of glaucoma is considered to be related
not only to primary risk factors such as the elevation of intraocular pressure, but also to …

Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: phase I study results

…, J Attias, R Bakimer, JB Marder, E Yoles… - … of Neurosurgery: Spine, 2005 - thejns.org
Object. A Phase I, open-label nonrandomized study was conducted to assess the safety and
tolerability of incubated autologous macrophages administered to patients with acute …

Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma

H Schori, J Kipnis, E Yoles… - Proceedings of the …, 2001 - National Acad Sciences
Our group recently demonstrated that autoimmune T cells directed against central nervous
system-associated myelin antigens protect neurons from secondary degeneration. We further …